HCA Healthcare, Inc. HCA NYSE

HCA Healthcare, Inc. (HCA) reported moderate year-over-year revenue growth of +7.1% through 2025-12 (TTM revenue vs prior-year TTM). Net income showed solid earnings growth of +17.8% YoY, reaching $1.9B in the latest quarter. The net profit margin is 9.6%, which is moderate. The company has maintained profitability in all 4 quarters. The gross margin is 52.4% (high), up 2.4pp vs the prior year. With a $112B market cap, MOAT composite score of 94/100 (strong competitive position).

Criteria proven by this page:

• GROWTH (65/100, Pass) — proving strong growth momentum
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 36-year annual history, the company was profitable in 35 of 36 years — an excellent long-term track record
• INCOME (45/100, Partial) — the company is profitable but margin is below 15%
• MOAT (94/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 61/100 with 5/7 criteria passed.